In short
A clinical trial is underway to assess the effectiveness of Tricortin 1000, a medication containing phospholipid from cerebral cortex and cyanocobalamin, in treating chronic low back pain. This double-blind, randomized study compares Tricortin 1000 with a placebo and an active control (diclofenac sodium medicated plaster) to determine its potential benefits for patients experiencing moderate to severe acute exacerbations of chronic low back pain.
At a glance
- Study Type
- Double-blind, randomized, placebo- and active-controlled clinical trial
- Main Treatment
- Tricortin 1000 (containing phospholipid from cerebral cortex and cyanocobalamin)
- Comparators
- Placebo and diclofenac sodium medicated plaster
- Target Condition
- Chronic low back pain with acute exacerbation
- Primary Outcome
- Change in pain relief from baseline to day 15
- Secondary Outcomes
- Disability improvement, clinical improvement, patient and clinical global assessments, rescue medication use, safety
- Treatment Duration
- 15 days
- Key Inclusion Criteria
- Age 40-70, chronic mechanical low back pain for 3-6 months, moderate to severe acute exacerbation
- Key Exclusion Criteria
- Non-specific low back pain, history of spine surgery, severe degenerative processes, contraindications to study medications
What is Tricortin 1000?
Tricortin 1000 is a medication being studied for the treatment of chronic low back pain. It contains two active ingredients: cyanocobalamin (a form of vitamin B12) and phospholipid from cerebral cortex (a substance derived from brain tissue). This medication is administered as an intramuscular injection, which means it's injected directly into a muscle.
Purpose of the Study
Researchers are conducting a clinical trial to evaluate how effective Tricortin 1000 is in treating chronic low back pain. The main goal is to see if Tricortin 1000 works better than a placebo (a substance with no active ingredients) in reducing pain after 15 days of treatment. They're also comparing it to another pain treatment called diclofenac sodium, which is applied as a medicated plaster on the skin.
How Tricortin 1000 Works
While the exact mechanism isn't fully explained in the study information, Tricortin 1000 is classified as a psychostimulant and nootropic drug. This suggests it may work by: Improving brain function and potentially affecting pain perception Providing neuroprotective effects, which could help with nerve-related pain Possibly reducing inflammation in the body The combination of vitamin B12 and brain-derived phospholipids may offer unique benefits for treating chronic pain conditions.
Who Can Participate in the Study?
The study is looking for participants who meet specific criteria, including: Adults aged 40-70 years old Diagnosed with chronic mechanical low back pain lasting 3-6 months Currently experiencing moderate to severe pain Not previously treated with Tricortin 1000 for low back pain Able to maintain a pain diary during the study There are also several conditions that would prevent someone from participating, such as: Pregnancy or breastfeeding History of certain medical conditions (e.g., cancer, severe heart disease) Recent physical therapy for low back pain Allergies to the study medications It's important to note that these are just some of the criteria, and a healthcare professional would need to evaluate each potential participant thoroughly.
Study Design
The study is designed as a double-blind, randomized, controlled trial. This means: Participants are randomly assigned to one of three groups: Tricortin 1000 injections Diclofenac sodium medicated plaster Placebo (inactive treatments) Neither the participants nor the researchers know who is receiving which treatment during the study The treatment period lasts for 15 days Researchers will measure pain levels and other factors at the beginning, middle, and end of the study This design helps ensure that the results are as unbiased and accurate as possible.
Potential Benefits
If Tricortin 1000 proves effective, it could offer several benefits for people with chronic low back pain: Reduced pain intensity Improved physical function and mobility Better quality of life A new treatment option for those who haven't found relief with other medications However, it's important to remember that the study is still ongoing, and these potential benefits are not yet proven.
Safety Considerations
As with any medical treatment, safety is a crucial concern. The study will closely monitor participants for any side effects or adverse reactions. Some important safety points to note: Tricortin 1000 is given as a daily intramuscular injection, which may cause some discomfort Participants will undergo regular physical examinations and vital sign checks The researchers will track any participants who withdraw from the study and why People with certain medical conditions or allergies are not eligible to participate, to minimize potential risks It's crucial to remember that this is an investigational treatment, and its full safety profile is still being studied.